Lazertinib Versus Gefitinib as First-Line Treatment in Patients with EGFR -Mutated Advanced Non-Small-Cell Lung Cancer: Results from LASER301
- Byoung Chul Cho
- , Myung Ju Ahn
- , Jin Hyoung Kang
- , Ross A. Soo
- , Thanyanan Reungwetwattana
- , James Chih Hsin Yang
- , Irfan Cicin
- , Dong Wan Kim
- , Yi Long Wu
- , Shun Lu
- , Ki Hyeong Lee
- , Yong Kek Pang
- , Anastasia Zimina
- , Chin Heng Fong
- , Elena Poddubskaya
- , Ahmet Sezer
- , Soon Hin How
- , Pongwut Danchaivijitr
- , Yukyung Kim
- , Yeji Lim
- Yonsei University
- Samsung Medical Center, Sungkyunkwan university
- National University Hospital
- Mahidol University
- National Taiwan University
- Trakya University
- Seoul National University
- Guangdong Academy of Medical Sciences
- Shanghai Jiao Tong University
- Chungbuk National University
- University of Malaya
- Omsk Clinical Oncological Dispensary
- Hospital Pulau Pinang
- Sechenov First Moscow State Medical University
- Adana Baskent Practice and Research Hospital
- Hospital Tengku Ampuan Afzan
- Yuhan Corporation
- University of Novi Sad
Research output: Contribution to journal › Article › peer-review
149
Scopus
citations